Outlook Therapeutics, Inc. Balance Sheet
OTLK|6 years of annual SEC 10-K data (FY2016-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 6 fiscal years. All figures from audited SEC 10-K filings.
Outlook Therapeutics, Inc. had $19M in total assets with negative shareholders' equity of $73M as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $8.1M | $12.5M | $8.0M | $3.2M | $2.4M | $9.1M |
| Accounts Receivable | $1.5M | - | - | - | - | - |
| Inventory | $3.3M | - | - | - | - | - |
| Current Assets | $17.4M | $17.9M | $13.5M | $3.3M | $3.9M | $5.7M |
| PP&E (Net) | - | $327.2K | $3.2M | $18.5M | $16.1M | $17.0M |
| Total Assets | $18.6M | $19.7M | $17.1M | $22.3M | $20.7M | $23.7M |
| Current Liabilities | $45.8M | $15.9M | $20.3M | $32.0M | $28.7M | $20.4M |
| Total Debt | - | - | $1.1M | $165.0K | $151.1K | $2.2M |
| Shareholders' Equity | -$73.1M | -$16.1M | -$25.5M | -$25.5M | -$33.7M | -$5.2M |